These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 26690378)
1. Antitoxin Treatment of Inhalation Anthrax: A Systematic Review. Huang E; Pillai SK; Bower WA; Hendricks KA; Guarnizo JT; Hoyle JD; Gorman SE; Boyer AE; Quinn CP; Meaney-Delman D Health Secur; 2015; 13(6):365-77. PubMed ID: 26690378 [TBL] [Abstract][Full Text] [Related]
2. Antitoxin Use in the Prevention and Treatment of Anthrax Disease: A Systematic Review. Hesse EM; Godfred-Cato S; Bower WA Clin Infect Dis; 2022 Oct; 75(Suppl 3):S432-S440. PubMed ID: 36251559 [TBL] [Abstract][Full Text] [Related]
3. Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident. Bower WA; Hendricks K; Pillai S; Guarnizo J; Meaney-Delman D; MMWR Recomm Rep; 2015 Dec; 64(4):1-22. PubMed ID: 26632963 [TBL] [Abstract][Full Text] [Related]
4. Systematic Review of Hospital Treatment Outcomes for Naturally Acquired and Bioterrorism-Related Anthrax, 1880-2018. Person MK; Cook R; Bradley JS; Hupert N; Bower WA; Hendricks K Clin Infect Dis; 2022 Oct; 75(Suppl 3):S392-S401. PubMed ID: 36251553 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Treatment for Systemic Anthrax: Analysis of Cases from 1945 to 2014 Identified Through a Systematic Literature Review. Pillai SK; Huang E; Guarnizo JT; Hoyle JD; Katharios-Lanwermeyer S; Turski TK; Bower WA; Hendricks KA; Meaney-Delman D Health Secur; 2015; 13(6):355-64. PubMed ID: 26623698 [TBL] [Abstract][Full Text] [Related]
6. Obiltoxaximab (Anthim) for inhalation anthrax. Med Lett Drugs Ther; 2018 Sep; 60(1555):150-151. PubMed ID: 30383733 [No Abstract] [Full Text] [Related]
7. Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax. Biron B; Beck K; Dyer D; Mattix M; Twenhafel N; Nalca A Antimicrob Agents Chemother; 2015 Apr; 59(4):2206-14. PubMed ID: 25645849 [TBL] [Abstract][Full Text] [Related]
8. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Hendricks KA; Wright ME; Shadomy SV; Bradley JS; Morrow MG; Pavia AT; Rubinstein E; Holty JE; Messonnier NE; Smith TL; Pesik N; Treadwell TA; Bower WA; Emerg Infect Dis; 2014 Feb; 20(2):. PubMed ID: 24447897 [TBL] [Abstract][Full Text] [Related]
9. Animal-to-Human Dose Translation of ANTHRASIL for Treatment of Inhalational Anthrax in Healthy Adults, Obese Adults, and Pediatric Subjects. Beliveau M; Rubets I; Bojan D; Hall C; Toth D; Kodihalli S; Kammanadiminti S Clin Pharmacol Ther; 2024 Feb; 115(2):248-255. PubMed ID: 38082506 [TBL] [Abstract][Full Text] [Related]
10. Obiltoxaximab: Adding to the Treatment Arsenal for Bacillus anthracis Infection. Hou AW; Morrill AM Ann Pharmacother; 2017 Oct; 51(10):908-913. PubMed ID: 28573869 [TBL] [Abstract][Full Text] [Related]
11. A Review of the Efficacy of FDA-Approved Couse Z; Cui X; Li Y; Moayeri M; Leppla S; Eichacker PQ Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33450877 [TBL] [Abstract][Full Text] [Related]
12. Does anthrax antitoxin therapy have a role in the treatment of inhalational anthrax? Vietri NJ Curr Opin Infect Dis; 2018 Jun; 31(3):257-262. PubMed ID: 29570493 [TBL] [Abstract][Full Text] [Related]
18. Obiltoxaximab: First Global Approval. Greig SL Drugs; 2016 May; 76(7):823-30. PubMed ID: 27085536 [TBL] [Abstract][Full Text] [Related]
19. Alternative pre-approved and novel therapies for the treatment of anthrax. Head BM; Rubinstein E; Meyers AF BMC Infect Dis; 2016 Nov; 16(1):621. PubMed ID: 27809794 [TBL] [Abstract][Full Text] [Related]